  
<prompt> Trends in IPTp
 Percentage of women with a live birth in the 2 years before the survey who received at least 1, 2, or 3 doses of SP/Fansidar 
 [["", "IPTp3+", "IPTp2+", "IPTp1+"], ["2009 UMIS", 17, 33, 47], ["2011 UDHS", 10, 27, 48], ["2014-15 UMIS", 28, 49, 64], ["2016 UDHS", 17, 46, 79], ["2018-19 UMIS", 41, 72, 89]] 
 <response> The percentage of women receiving IPTp1+ increased from 47% in the 2009 UMIS to 89% in the 2018-19 UMIS. The percentage of women receiving two or more doses of SP/Fansidar for IPTp increased from 33% in the 2009 UMIS to 72% in the 2018-19 UMIS. Similarly, the percentage of women receiving three or more doses of SP/Fansidar for IPTp increased from 17% in the 2009 UMIS to 41% in the 2018-19 UMIS  